Pharmacogenomics of autism spectrum disorder

Impact of CYP2D6 Polymorphism on Steady-State Plasma Levels of Risperidone and 9-Hydroxyrisperidone in Thai Children and Adolescents with Autism Spectrum Disorder

(2017) Natchaya Vanwong et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

9-Hydroxyrisperidone-Induced Hyperprolactinaemia in Thai Children and Adolescents with Autism Spectrum Disorder

(2016) Nattawat Ngamsamut et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Single dose, CYP2D6 genotype-stratified pharmacokinetic study of atomoxetine in children with ADHD

(2016) JT Brown et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Detection of CYP2D6 polymorphism using Luminex xTAG technology in autism spectrum disorder: CYP2D6 activity score and its association with risperidone levels

(2016) Natchaya Vanwong et al.   Drug Metabolism and Pharmacokinetics

Impact of Pharmacogenetic Markers of CYP2D6 and DRD2 on Prolactin Response in Risperidone-Treated Thai Children and Adolescents With Autism Spectrum Disorders

(2016) Chonlaphat Sukasem et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Complex genomic variants contribute toward the genetic architecture of autism spectrum disorder

(2016) Chia-Hsiang Chen et al.   PSYCHIATRIC GENETICS

Pharmacogenetic Associations of Antipsychotic Drug-Related Weight Gain: A Systematic Review and Meta-analysis

(2016) Jian-Ping Zhang et al.   SCHIZOPHRENIA BULLETIN

Healthcare transition challenges faced by young adults with autism spectrum disorder

(2015) T Hall et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Pharmacogenetic Study of Serotonin Transporter and 5HT2A Genotypes in Autism

(2015) Fedra Najjar et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

The Influence of the CYP3A4*22 Polymorphism and CYP2D6 Polymorphisms on Serum Concentrations of Aripiprazole, Haloperidol, Pimozide, and Risperidone in Psychiatric Patients

(2015) Karen van der Weide et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

The effect of antidepressants and antipsychotics on weight gain in children and adolescents

(2015) J. Reekie et al.   Obesity Reviews

CYP2D6 genotyping in paediatric patients with autism treated with risperidone: a preliminary cohort study

(2014) Ilan Youngster et al.   DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY

Effect of polymorphisms on the pharmacokinetics, pharmacodynamics, and safety of risperidone in healthy volunteers

(2014) Teresa Cabaleiro et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Atomoxetine in Autism Spectrum Disorder: No Effects on Social Functioning; Some Beneficial Effects on Stereotyped Behaviors, Inappropriate Speech, and Fear of Change

(2014) Myriam Harfterkamp et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Practice Parameter for the Assessment and Treatment of Children and Adolescents With Autism Spectrum Disorder

(2014) Fred Volkmar et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

Synaptic, transcriptional and chromatin genes disrupted in autism

(2014) Silvia De Rubeis et al.   NATURE

Effects of Genetic Polymorphisms of CYP2D6, CYP3A5, and ABCB1 on the Steady-State Plasma Concentrations of Aripiprazole and Its Active Metabolite, Dehydroaripiprazole, in Japanese Patients With Schizophrenia

(2014) Takeshi Suzuki et al.   THERAPEUTIC DRUG MONITORING

Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs

(2013) S Hong Lee et al.   NATURE GENETICS

Rare Inherited Variation in Autism: Beginning to See the Forest and a Few Trees

(2013) Jason L. Stein et al.   NEURON

The effect of the Taq1A variant in the dopamine D2 receptor gene and common CYP2D6 alleles on prolactin levels in risperidone-treated boys

(2013) Yvette Roke et al.   Pharmacogenetics and Genomics

Positive effects of methylphenidate on hyperactivity are moderated by monoaminergic gene variants in children with autism spectrum disorders

(2013) J T McCracken et al.   PHARMACOGENOMICS JOURNAL

Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies

(2013) E L Nurmi et al.   Translational Psychiatry

Body Weight and Metabolic Adverse Effects of Asenapine, Iloperidone, Lurasidone and Paliperidone in the Treatment of Schizophrenia and Bipolar Disorder

(2012) Marc De Hert et al.   CNS DRUGS

Common genetic variants, acting additively, are a major source of risk for autism

(2012) Lambertus Klei et al.   Molecular Autism

Genetic Heritability and Shared Environmental Factors Among Twin Pairs With Autism

(2011) Joachim Hallmayer   ARCHIVES OF GENERAL PSYCHIATRY

Aripiprazole in the Treatment of Irritability Associated with Autistic Disorder in Paediatric Patients†

(2011) Monique P. Curran   CNS DRUGS

Weight Gain and Metabolic Risks Associated with Antipsychotic Medications in Children and Adolescents

(2011) Lawrence Maayan et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Gene expression in blood is associated with risperidone response in children with autism spectrum disorders

(2011) L Lit et al.   PHARMACOGENOMICS JOURNAL

A genome-wide scan for common alleles affecting risk for autism

(2010) R. Anney et al.   HUMAN MOLECULAR GENETICS

Risperidone-Induced Weight Gain in Referred Children with Autism Spectrum Disorders Is Associated with a Common Polymorphism in the 5-Hydroxytryptamine 2C Receptor Gene

(2010) Pieter J. Hoekstra et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Functional Genomics of Serotonin Receptor 2A (HTR2A): Interaction of Polymorphism, Methylation, Expression and Disease Association

(2010) Virginia R. Falkenberg et al.   NEUROMOLECULAR MEDICINE

Polymorphisms of theHTR2Cgene and antipsychotic-induced weight gain: an update and meta-analysis

(2010) Michelle N Sicard et al.   PHARMACOGENOMICS

Lack of Efficacy of Citalopram in Children With Autism Spectrum Disorders and High Levels of Repetitive Behavior

(2009) Bryan H. King et al.   ARCHIVES OF GENERAL PSYCHIATRY

Characteristics and Concordance of Autism Spectrum Disorders Among 277 Twin Pairs

(2009) Rebecca E. Rosenberg et al.   ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE

Citalopram efficacy study; interstitial 15q11-q13 duplication mouse

(2009) Edwin H. Cook   Autism Research

A Placebo-Controlled, Fixed-Dose Study of Aripiprazole in Children and Adolescents With Irritability Associated With Autistic Disorder

(2009) Ronald N. Marcus et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

Common genetic variants on 5p14.1 associate with autism spectrum disorders

(2009) Kai Wang et al.   NATURE

Aripiprazole in the Treatment of Irritability in Children and Adolescents With Autistic Disorder

(2009) R. Owen et al.   PEDIATRICS

Pharmacogenetics of risperidone therapy in autism: association analysis of eight candidate genes with drug efficacy and adverse drug reactions

(2009) C T Correia et al.   PHARMACOGENOMICS JOURNAL

Effect of dopamine D3 receptor gene polymorphisms and clozapine treatment response: exploratory analysis of nine polymorphisms and meta-analysis of the Ser9Gly variant

(2009) R Hwang et al.   PHARMACOGENOMICS JOURNAL

Prolactin and dopamine: What is the connection? A Review Article

(2008) Peter Fitzgerald et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Psychotropic Medication Use Among Medicaid-Enrolled Children With Autism Spectrum Disorders

(2008) D. S. Mandell et al.   PEDIATRICS